Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine

Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine

<i>Streptococcus agalactiae</i> (group B <i>Streptococcus</i>, GBS) is a leading cause of neonatal sepsis and meningitis in infants. Limitations of prenatal GBS screening and intrapartum antibiotic prophylaxis render developing GBS vaccines a high priority. In this study, we...

Full description

Bibliographic Details
Main Authors: A-Yeung Jang, Min-Joo Choi, Yong Zhi, Hyun-Jung Ji, Ji-Yun Noh, Jin-Gu Yoon, Hee-Jin Cheong, Woo-Joo Kim, Ho-Seong Seo, Joon-Young Song
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
<i>Streptococcus agalactiae</i>
capsular polysaccharide
enzyme-linked immunosorbent assay
validation
vaccine
Online Access:https://www.mdpi.com/2076-393X/9/6/545

Internet

https://www.mdpi.com/2076-393X/9/6/545

Similar Items